The Batten disease associated protein CLN3 is required for the efflux of lysosomal K+MOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Glycosphingolipid reduction with miglustat as a therapeutic strategy for CLN3 and other neuronal ceroid lipofuscinosesMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE
Measuring ion flux via lysosomal channels: Primary and secondary assays for drug discovery across the lysosomal disordersMOLECULAR GENETICS AND METABOLISMIF3.52023-02-010PRE